Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.56 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29995636 | 1.00 | FTO (0.56) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL29501272 | 1.00 | FTO (0.56) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL30064563 | 1.00 | FTO (0.56) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL29579867 | 0.96 | FTO (0.55) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL334086 | 0.93 | FTO (0.55) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL31580193 | 0.93 | FTO (0.55) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL29383733 | 0.93 | FTO (0.55) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL27645069 | 0.88 | FTO (0.52) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL20339897 | 0.88 | FTO (0.53) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL29569825 | 0.87 | ALDH1A1 (0.46) | FTOMAPTMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250002954-A1 | Novel Compound, Use Thereof, and Method for Producing Same, and Compound-Containing Composition, Method for Producing 4-Trehalosamine, and Microorganism | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2025-01-02 | — | — | US | claimed |
| CN-118922553-A | Novel compound, use thereof, preparation method thereof, composition containing compound, preparation method of 4-trehalose amine and microorganism | 公益财团法人微生物化学研究会 | 2024-11-08 | — | — | CN | claimed |
| US-12105092-B2 | Molecularly imprinted particles | GEORGE MASON UNIVERSITY (US) | 2024-10-01 | — | — | US | claimed |
| EP-4400596-A1 | NOVEL COMPOUND, USE THEREOF, METHOD FOR PRODUCING SAME, COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING 4-TREHALOSAMINE, AND MICROORGANISM | Microbial Chemistry Research Foundation (JP) | 2024-07-17 | — | — | EP | claimed |
| WO-2023032788-A1 | NOVEL COMPOUND, USE THEREOF, METHOD FOR PRODUCING SAME, COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING 4-TREHALOSAMINE, AND MICROORGANISM | 公益財団法人微生物化学研究会 | 2023-03-09 | — | — | WO | claimed |
| CN-114199653-A | Microbial immunofluorescence staining solution for vagina | 济南德亨医学科技有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-110643032-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-111620918-A | 8-beta-D-glucopyranose-4', 7-dihydroxyisoflavone FAM derivative and synthetic method thereof | 辽宁中医药大学 | 2020-09-04 | — | — | CN | claimed |
| CN-109553566-B | Anti-counterfeiting material with adjustable imaging waveband and preparation method and application thereof | 北京化工大学 | 2020-05-01 | — | — | CN | claimed |
| CN-110643032-A | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2020-01-03 | — | — | CN | claimed |
| WO-2014209300-A1 | ELECTROPHORETIC DISPLAYS HAVING CHARGED FLUORESCENT DENDRIMER PARTICLES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-12-31 | — | — | WO | claimed |
| CN-101735802-A | Double-chromophore fluorescent probe and preparation method | UNIV TIANJIN POLYTECHNIC | 2010-06-16 | — | — | CN | claimed |
| US-12454531-B2 | Substituted piperazine derivatives useful as T cell activators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-10-28 | — | — | US | disclosed |
| CN-120192374-A | Targeted SctV cyclic peptide for inhibiting T3SS activity and application thereof | 山东大学 | 2025-06-24 | — | — | CN | disclosed |
| US-20250002954-A1 | Novel Compound, Use Thereof, and Method for Producing Same, and Compound-Containing Composition, Method for Producing 4-Trehalosamine, and Microorganism | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2025-01-02 | — | — | US | disclosed |
| CN-118922553-A | Novel compound, use thereof, preparation method thereof, composition containing compound, preparation method of 4-trehalose amine and microorganism | 公益财团法人微生物化学研究会 | 2024-11-08 | — | — | CN | disclosed |
| US-4912208-A | Spiro(phthalan-1,9'-xanthene) ring | ABBOTT LABORATORIES (US) | 1990-03-27 | — | — | US | disclosed |
| EP-0108399-B1 | SUBSTITUTED CARBOXYFLUORESCEINS | ABBOTT LABORATORIES (US) | 1987-09-23 | — | — | EP | disclosed |
| US-4476229-A | QUANTITATIVE ANALYSIS OF LIGANDS IN BIOLOGICAL FLUIDS | ABBOTT LABORATORIES (US) | 1984-10-09 | — | — | US | disclosed |
| EP-0108399-A2 | Substituted carboxyfluoresceins | ABBOTT LABORATORIES (US) | 1984-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12454531-B2 | Substituted piperazine derivatives useful as T cell activators | DGKZ, DGKA, DGKG | FTO 4445/4885MAPT 4488/4885MEN1 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.